Central Nervous System Lymphomas

  • H. Loiseau
  • E. Cuny
  • A. Vital
  • F. Cohadon
Part of the Advances and Technical Standards in Neurosurgery book series (NEUROSURGERY, volume 26)


According to the current nomenclature and textbooks (Jellinger and Paulus, 1992; Burger and Scheithauer, 1994; Burger and Scheithauer, 1994; Rosenthal and Green, 1995), the different circumstances in which a lymphoma may affect the central nervous system (CNS) are listed below.


Primary Central Nervous System Lymphoma Mycosis Fungoides Central Nervous System Lymphoma Intraocular Lymphoma Lymphomatoid Granulomatosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alderson L, Fetell MR, Sisti M, Hochberg F, Cohen M, Louis DN (1996) Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry 60: 102–105PubMedGoogle Scholar
  2. 2.
    Apuzzo MLJ, Chandrasoma PT, Cohen D, Zee CS, Zelman V (1987) Computed imaging stereotaxy: experience and perspective related to 500 procedures applied to brain masses. Neurosurgery 20: 930–937PubMedGoogle Scholar
  3. 3.
    Ashby MA, Barber PC, Holmes AE, Freer CEL, Collins RD (1988) Primary intracranial Hodgkin’s disease. A case report and discussion. Am J Surg Pathol 12: 294–299PubMedGoogle Scholar
  4. 4.
    Balmaceda C, Gaynor JJ, Sun M, Gluck JT, DeAngelis LM (1995) Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications. Ann Neurol 38: 202–209PubMedGoogle Scholar
  5. 5.
    Bataille B, Daban A, Delwail V, Menet E, Vandermarcq P (1997) Lymphomes cérébraux primitifs. Neurochirurgie 43: 347–391Google Scholar
  6. 6.
    Bernstein M, Parrent AG (1994) Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 81: 165–168PubMedGoogle Scholar
  7. 7.
    Blay JY, Bouhour D, Carrie C, Bouffet E, Brunat-Mentigny M, Philip T, Biron P (1995) The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin’s lymphoma of patients with no known cause of immunosuppression. Blood 86: 2922–2929PubMedGoogle Scholar
  8. 8.
    Blay JY, Conroy T, Chevreau C, Thyss A, Quesnel N, Eghbali H, Bouabdallah R, Coiffier B, Wagner JP, Le Mevel A, Dramais-Marcel D, Baumelou E, Chauvin F, Biron P (1998) High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 16: 864–871PubMedGoogle Scholar
  9. 9.
    Bleyer WA (1981) Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep 65 [Suppl] 1: 89–98PubMedGoogle Scholar
  10. 10.
    Bloomfield CD, Smith KA, Peterson BA, Gajl-Peczalska KJ, Munck AU (1981) In vitro glucocorticoid studies in human lymphoma: clinical and biological significance. J Steroid Biochem 15: 275–284PubMedGoogle Scholar
  11. 11.
    Bodensteiner DC, Skikne B (1982) Central nervous system involvement in mycosis fungoides. Diagnosis, treatment and literature review. Cancer 50: 1181–1184PubMedGoogle Scholar
  12. 12.
    Bogdahn U, Bogdahn S, Mertens HG, Dommasch D, Wodarz R, Wünsch PH, Kühl P, Richter E (1986) Primary non-Hodgkin’s lymphomas of the CNS. Acta Neurol Scand 73: 602–614PubMedGoogle Scholar
  13. 13.
    Boiardi A, Silvani A, Valentini S, Salmaggi A, Allegranza A, Broggi G (1993) Chemotherapy as first treatment for primary malignant non-Hodgkin’s lymphoma of the central nervous system preliminary data. J Neurol 241: 96–100PubMedGoogle Scholar
  14. 14.
    Brada M (1995) Central nervous system lymphomas: progress in chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 33: 769–771PubMedGoogle Scholar
  15. 15.
    Brada M, Dearnley D, Horwich A, Bloom HJG (1990) Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 18: 787–792PubMedGoogle Scholar
  16. 16.
    Burger PC, Scheithauer BW (1994) Metastatic and secondary neoplasms. Tumors of the Central Nervous System (ed) AFIo Pathology. Bethesda, pp 415–428Google Scholar
  17. 17.
    Burger PC, Scheithauer BW (1994) Primary tumors of hematopoietic tissue. Tumors of the Central Nervous System (ed) AFIo Pathology. Bethesda, pp 321–328Google Scholar
  18. 18.
    Cairncross JG, Macdonald DR, Pexman JHW, Ives FJ (1988) Steroidinduced CT changes in patients with recurrent malignant glioma. Neurology 38: 724–726PubMedGoogle Scholar
  19. 19.
    Carli PM, Boutron MC, Maynadié M, Bailly F, Caillot D, Petrella T (1994) Increase in the incidence of non-Hodgkin’s lymphomas: evidence for a recent sharp increse in France independent of AIDS. Br J Cancer 70: 713–715PubMedGoogle Scholar
  20. 20.
    Chamberlain MC, Levin VA (1990) Adjuvant chemotherapy for primary lymphoma of the central nervous system. Arch Neurol 47: 1113–1116PubMedGoogle Scholar
  21. 21.
    Chang KL, Flaris N, Hickey WF, Johnson RM, Meyer JS, Weiss LM (1993) Brain lymphomas of immunocompetent and immunocompromised patients: study of the association with Epstein-Barr virus. Mod Pathol 6: 427–432PubMedGoogle Scholar
  22. 23.
    Chapin JE, Davis LE, Kornfeld M, Mandler RN (1995) Neurologic manifestations of intravascular lymphomatosis. Acta Neurol Scand 91: 494–499PubMedGoogle Scholar
  23. 24.
    Clark WC, Callihan T, Schwartzberg L, Fontanesi J (1992) Primary intracranial Hodgkin’s lymphoma without dural attachment. Case report. J Neurosurg 76: 692–695PubMedGoogle Scholar
  24. 25.
    Corn BW, Marcus SM, Topham A, Hauck W, Curran WJ Jr. (1997) Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 79: 2409–2413PubMedGoogle Scholar
  25. 26.
    Corry J, Smith JG, Wirth A, Quong G, Liew KH (1998) Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int J Radiat Oncol Biol Phys 41: 615–620PubMedGoogle Scholar
  26. 27.
    Cuny E, Loiseau H, Cohadon F (1998) Lymphomes primitifs du système nerveux central. Rôle diagnostique et pronostique des rémissions corticoinduites. Neurochirurgie 44: 19–24PubMedGoogle Scholar
  27. 28.
    DeAngelis LM (1995) Current management of primary central nervous system lymphoma. Oncology 9: 63–71PubMedGoogle Scholar
  28. 29.
    DeAngelis LM (1994) Primary central nervous system lymphoma. Rec Res Cancer Res 135: 155–169Google Scholar
  29. 30.
    DeAngelis LM (1990) Primary central nervous system lymphoma imitates multiple sclerosis. J Neurooncol 9: 177–181PubMedGoogle Scholar
  30. 31.
    DeAngelis LM (1991) Primary central nervous system lymphoma: a new clinical challenge. Neurology 41: 619–621PubMedGoogle Scholar
  31. 32.
    Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62: 2461–2465PubMedGoogle Scholar
  32. 33.
    Ersbøll J, Schultz HB, Thomsen BLR, Keiding N, Nissen NI (1985) Meningeal involvement in non-Hodgkin’s lymphoma: symptoms, incidence, risk factors and treatment. Scand J Haematol 35: 487–496.PubMedGoogle Scholar
  33. 34.
    Ferracini R, Pileri S, Bergmann M, Sabattini E, Rigobello L, Gambacorta M, Galli C, Manetto V, Frank G, Godano U, Spagnolli F, Casadei G, Azzolini U, Falini B, Gullotta F (1993) Non-Hodgkin lymphomas of the central nervous system. Clinico-pathologic and immunohistochemical study of 147 cases. Path Res Pract 189: 249–260PubMedGoogle Scholar
  34. 35.
    Ferreri AJM, Reni M, Villa E (1995) Primary central nervous system lymphoma in immunocompetent patients. Cancer Treat Rev 21: 415–446PubMedGoogle Scholar
  35. 36.
    Fine HA (1995) Treatment of primary central nervous system lymphoma: still more questions than answers. Blood 86: 2873–2875PubMedGoogle Scholar
  36. 37.
    Fine HA, Mayer RJ (1993) Primary central nervous system lymphoma. Ann Intern Med 119: 1093–1104PubMedGoogle Scholar
  37. 38.
    Freilich RJ, DeAngelis LM (1995) Primary central nervous system lymphoma. Neurol Clin 13: 901–914PubMedGoogle Scholar
  38. 39.
    Freilich RJ, Delattre JY, Monjour A, DeAngelis LM (1996) Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 46: 435–439PubMedGoogle Scholar
  39. 40.
    Gabbai AA, Hochberg FH, Linggood RM, Bashir R, Hotleman K (1989) High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases. J Neurosurg 70: 190–194PubMedGoogle Scholar
  40. 41.
    Gametchu B (1987) Glucocorticoid receptor-like antigen in lymphoma cell membranes: correlation to cell lysis. Science 236: 456–461PubMedGoogle Scholar
  41. 42.
    Garcia-Monco JC, Benach JL (1995) Lyme neuroborreliosis. Ann Neurol 1995 (37): 691–702Google Scholar
  42. 43.
    Geddes JF, Bhattacharjee MB, Savage K, Scaravilli F, McLaughlin JE (1992) Primary cerebral lymphoma: a study of 47 cases probed for Epstein-Barr virus genome. J Clin Pathol 45: 587–590PubMedGoogle Scholar
  43. 44.
    Geppert M, Ostertag C, Seitz G, Kiessling M (1990) Glucocorticoid therapy obscures the diagnosis of cerebral lymphoma. Acta Neuropathol 80: 629–634PubMedGoogle Scholar
  44. 45.
    Glass J, Gruber ML, Cher L, Hochberg FH (1994) Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long term outcome. J Neurosurg 81: 188–195PubMedGoogle Scholar
  45. 46.
    Grant JW, Isaacson PG (1992) Primary central nervous system lymphoma. Brain Pathol 2: 97–109PubMedGoogle Scholar
  46. 47.
    Hallahan D, Griem M, Griem S, Duda E, Baron J (1986) Mycosis fungoides involving the central nervous system. J Clin Oncol 4: 1638–1644PubMedGoogle Scholar
  47. 48.
    Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA et al (1994) A revised European-American Classification of Lymphoid Neoplasms: a proposal from the international lymphoma study group. Blood 84: 1361–1392PubMedGoogle Scholar
  48. 49.
    Hayakawa T, Takakura K, Abe H, Yoshimoto T, Tanake R, Sugita K, Kikuchi H, Uozumi T, Hori T, Fukui H, Ushio Y, Nomura K, Matsutani M, Mohri N, Kumanishi T, Aozasa K, Nagashima K (1994) Primary central nervous system lymphoma in Japan. A retrospective, cooperative study by CNS-Lymphoma Study Group in Japan. J Neurooncol 19: 197–215PubMedGoogle Scholar
  49. 50.
    Heinzleff O, Poisson M, Delattre JY (1996) Régression spontanée d’un lymphome cérébral primitif. Rev Neurol 152: 135–138Google Scholar
  50. 51.
    Henry JM, Heffner RR Jr, Dillard SH, Earle KM, Davis RL (1974) Primary malignant lymphomas of the central nervous system. Cancer 34: 1293 – 1302PubMedGoogle Scholar
  51. 52.
    Herrlinger U, Schabet M, Eichhorn M, Petersen D, Grote EH, Meyermann R, Dichgans J (1996) Prolonged corticosteroid-induced remission in primary central nervous system lymphoma: report of a case and review of the literature. Eur Neurol 36: 241–243PubMedGoogle Scholar
  52. 53.
    Hochberg FH, Loeffler JS, Prados M (1991) The therapy of primary brain lymphoma. J NeuroOncol 10: 191–201PubMedGoogle Scholar
  53. 54.
    Hochberg FH, Miller DC (1988) Primary central nervous system lymphoma. J Neurosurg 68: 835–853PubMedGoogle Scholar
  54. 55.
    Horning SJ, Rosenberg SA (1984) The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Eng J Med 311: 1471–1475Google Scholar
  55. 56.
    Jack CR Jr, O’Neill BP, Banks PM, Reese DF (1988) Central nervous system lymphoma: histologic types and CT appearance. Radiology 167: 211–213PubMedGoogle Scholar
  56. 57.
    Jackson RJ, Goodman JC, Huston DP, Harper RL (1998) Parafalcine and bilateral convexity neurosarcoidosis mimicking meningioma: case report and review of the literature. Neurosurgery 42: 635–638PubMedGoogle Scholar
  57. 58.
    Jellinger KA, Paulus W (1992) Primary central nervous system lymphomas — an update. J Cancer Res Clin Oncol 119: 7–27PubMedGoogle Scholar
  58. 59.
    Kanavaros P, Mikol J, Nemeth J, Galian A, Dupont B, Thiebaut JB, Thurel C (1990) Stereotactic biopsy diagnosis of primary non-Hodgkin’s lymphoma of the central nervous system. A histological and immunohistochemical study. Path Res Pract 186: 459–466PubMedGoogle Scholar
  59. 60.
    Keldsen N, Michalski W, Bentzen SM, Hansen KB, Thorling K (1996) Risk factors for central nervous system involvement in non-Hodgkin’s-lymphoma. A multivariate analysis. Acta Oncol 35: 703–708PubMedGoogle Scholar
  60. 61.
    Kepes JJ (1993) Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 33: 18–27PubMedGoogle Scholar
  61. 62.
    Kumanishi T, Washiyama A, Nishiyama A, Abe S, Saito T, Ichikawa T (1989) Primary malignant lymphoma of the brain: demonstration of immunoglobulin gene rearrangements in four cases by the Southern blot hybridization technique. Acta Neuropathol 79: 23–26PubMedGoogle Scholar
  62. 63.
    Kuroda Y, Kawasaki T, Haraoka S, Fujiyama F, Kakigi R, Abe M, Tabuchi K, Kuroiwa T, Kishikawa T, Sugihara H (1992) Autopsy report of primary CNS B-cell lymphoma indistinguishable from multiple sclerosis: diagnosis with the immunoglobulin gene rearrangement analysis. J Neurol Sci: 173–179Google Scholar
  63. 64.
    Lachance DH, O’Neill BP, Macdonald DR, Jaeckle KA, Witzig TE, Li CY, Posner JB (1991) Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature. Neurology 41: 95–100PubMedGoogle Scholar
  64. 65.
    Leal Filipe P, Sousa Coutinho V, Canhào P, Gouveia R, Cabeçadas J, Osorio A, Lobo Antunes J (1994) Mycosis fungoides with early central nervous system involvement. Acta Derm Venereol 1994: 63–64Google Scholar
  65. 66.
    Lee YY, Bruner JM, Van Tassel P, Libshitz HI (1986) Primary central nervous system lymphoma: CT and pathologic correlation. AJR 147: 747–752PubMedGoogle Scholar
  66. 67.
    Leibel SA, Sheline GE (1987) Radiation therapy for neoplasms of the brain. J Neurosurg 66: 1–22PubMedGoogle Scholar
  67. 68.
    Lennert K, Feller AC (1990) Histopathology of non-Hodgkin’s lymphomas (based on the updated Kiel classification). Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  68. 69.
    Lieberman AN, Foo SH, Ransohoff J, Wise A, George A, Gordon W, Walker R (1982) Long term survival among patients with malignant brain tumors. Neurosurgery 10: 450–453PubMedGoogle Scholar
  69. 70.
    Loeffler JS, Ervin TJ, Mauch P, Skarin A, Weinstein HJ, Canellos G, Cassady JR (1985) Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 3: 490–494PubMedGoogle Scholar
  70. 71.
    Loiseau H, Pedespan JM, Vital A, Marchai C, Vital C, Cohadon F (1995) Lymphoplasmocyte-rich meningioma in a child. Case report. J Neurosurg 83: 1075–1079PubMedGoogle Scholar
  71. 72.
    Lutz JM, Coleman MP (1994) Trends in primary cerebral lymphoma. Br J Cancer 70: 716–718PubMedGoogle Scholar
  72. 73.
    Mead GM, Kennedy P, Smith JL, Thompson J, Macbeth FRM, Ryall RDH, Williams CJ, Whitehouse JMA (1986) Involvement of the central nervous system by non-Hodgkin’s lymphoma in adults. A review of 36 cases. Quart J Med 60: 699–714PubMedGoogle Scholar
  73. 74.
    Michalski JM, Garcia DM, Kase E, Grigsby PW, Simpson JR (1990) Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure. Radiology 176: 855–860PubMedGoogle Scholar
  74. 75.
    Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H (1994) Pathology with clinical correlations of primary central nervous system non-Hodgkin’s lymphoma. The Massachusetts General Hospital Experience 1958–1989. Cancer 74: 1383–1397PubMedGoogle Scholar
  75. 76.
    Murray K, Kun L, Cox J (1986) Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg 65: 600–607PubMedGoogle Scholar
  76. 77.
    Nakamine H, Yokote H, Itakura T, Hayashi S, Komai N, Takano Y, Saito K, Moriwaki H, Nishino E, Takenada T, Maeda J, Matsumori T (1989) Non-Hodgkin’s lymphoma involving the brain. Diagnostic usefulness of stereotactic needle biopsy in combination with paraffin-section immunohistochemistry. Acta Neuropathol 78: 462–471PubMedGoogle Scholar
  77. 78.
    Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman HD, Thomson JW, Murray KJ (1992) Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the radiation therapy oncology group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 9–17Google Scholar
  78. 79.
    Neuwelt EA, Goldman DL, Dahlborg SA, Crossen J, Ramsey F, Roman-Goldstein S, Braziel R, Dana B (1991) Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9: 1580–1590PubMedGoogle Scholar
  79. 80.
    Novak JA, Katzin WE (1995) Primary central nervous system T-cell lymphoma with a predominant CD8 immunophenotype. Cancer 75: 2180 – 2185PubMedGoogle Scholar
  80. 81.
    O’Neill BP, Illig JJ (1989) Primary central nervous sytem lymphoma. Mayo Clin Proc 64: 1005–1020PubMedGoogle Scholar
  81. 82.
    O’Neill BP, Kelly PJ, Earle JD, Scheithauer B, Banks PM (1987) Computerassisted stereotaxic biopsy for the diagnosis of primary central nervous system lymphoma. Neurology 37: 1160–1164PubMedGoogle Scholar
  82. 83.
    O’Neill BP, O’Fallon JR, Earle JD, Colgan JP, Brown LD, Krigel RL (1995) Primary central nervous system non-Hodgkin’s lymphoma: survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys 33: 663–673PubMedGoogle Scholar
  83. 84.
    Paulus W, Jellinger K, Morgello S (1997) Malignant lymphomas. Pathology and Genetics of Tumours of the Nervous System. Kleihues P, Cavenee WK (eds) IARC, Lyon, pp 154–159Google Scholar
  84. 85.
    Paulus W, Ott MM, Strik H, Keil V, Müller-Hermelink HK (1994) Large cell anaplastic (KI-1) brain lymphoma of T-cell genotype. Hum Pathol 25: 1253–1256PubMedGoogle Scholar
  85. 86.
    Penn I (1977) Development of cancer as a complication of clinical transplantation. Transpl Proc 9: 1221–1127Google Scholar
  86. 87.
    Peterson K, Gordon KB, Heinemann MH, DeAngelis LM (1993) The clinical spectrum of ocular lymphoma. Cancer 72: 843–849PubMedGoogle Scholar
  87. 88.
    Pollack IA, Lunsford LD, Flickinger JC, Dameshek HL (1989) Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63: 939–947PubMedGoogle Scholar
  88. 89.
    Qualman SJ, Mendelsohn G, Mann RB, Green WR (1983) Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer 52: 878–886PubMedGoogle Scholar
  89. 90.
    Remick SC, Diamond C, Migliozzi JA, Solis O, Wagner H Jr, Haase RF, Ruckdeschel JC (1990) Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature. Medicine 69: 345–360PubMedGoogle Scholar
  90. 91.
    Reni M, Ferreri AJM, Zoldan MC, Villa E (1997) Primary brain lymphomas in patients with a prior or concomitant malignancy. J Neurooncol 32: 135–142PubMedGoogle Scholar
  91. 92.
    Revesz T, Scaravilli F, Coutinho L, Cockburn H, Sacares P, Thomas DGT (1993) Reliability of histological diagnosis including grading in gliomas biopsed by image-guided stereotactic technique. Brain 116: 781–793PubMedGoogle Scholar
  92. 93.
    Riou JP, Ariyan S, Brandow KR, Fielding LP (1995) The association between melanoma, lymphoma, and other primary neoplasms. Arch Surg 130: 1056–1061PubMedGoogle Scholar
  93. 94.
    Rosenberg SA (1994) Classification of lymphoid neoplasms. Blood 84: 1359–1360PubMedGoogle Scholar
  94. 95.
    Rosenthal MA, Green MD (1995) Cerebral lymphoma. Brain Tumors. An encyclopedic approach. In: Kaye AH, Laws Jr ER (eds) Churchill Livingstone, Edinburgh Hong Kong, pp 841–869Google Scholar
  95. 96.
    Scherer HJ (1940) The forms of growth in gliomas and their practical significance. Brain 63: 1–35Google Scholar
  96. 97.
    Schmidt BJ, Meagher-Villemure K, Del Carpio J (1984) Lymphomatoid granulomatosis with isolated involvement of the brain. Ann Neurol 15: 478–481PubMedGoogle Scholar
  97. 98.
    Schultz C, Scott C, Sherman W, Donahue B, Fields J, Murray K, Fisher B, Abrams R, Meis-Kindblom J (1996) Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group Protocol 88–06. J Clin Oncol 14: 556–564PubMedGoogle Scholar
  98. 99.
    Schwechheimer K, Braus DF, Schwarzkopf G, Feller AC, Volk B, Müller-Hermelink HK (1994) Polymorphous high-grade B cell lymphoma is the predominant type of spontaneous primary cerebral malignant lymphomas. Histological and immunomorphological evaluation of computed tomography-guided stereotactic brain biopsies. Am J Surg Pathol 18: 931–937PubMedGoogle Scholar
  99. 100.
    Schwechheimer K, Schwarzkopf G, Braus DF, Müller-Hermelink HK, Volk B (1989) Primary cerebral malignant non-Hodgkin’s lymphomas. Histological and immunopathological findings on stereotactic brain biopsies. Clin Neuropathol 8: 250–251Google Scholar
  100. 101.
    Selch MT, Shimizu KT, De Salles AF, Sutton C, Parker RG (1994) Primary central nervous system lymphoma. Results at the University of California at Los Angeles and review of the literature. Am J Clin Oncol 17: 286–293PubMedGoogle Scholar
  101. 102.
    Severson RK, Davis S (1990) Increasing evidence of primary gastric lymphoma. Cancer 66: 1283–1287PubMedGoogle Scholar
  102. 103.
    Sherman ME, Erozan YS, Mann RB, Kumar AAJ, McArthur JC, Royal W, Uematsu S, Nauta HJW (1991) Stereotactic brain biopsy in the diagnosis of malignant lymphoma. Am J Clin Pathol 95: 878–883PubMedGoogle Scholar
  103. 104.
    Shibamoto Y, Tsutsui K, Dodo Y, Yamabe H, Shima N, Abe M (1990) Improved survival rate in primary intracranial lymphoma treated by highdose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer 65: 1907–1912PubMedGoogle Scholar
  104. 105.
    Shibata S (1989) Sites of origin of primary intracerebral malignant lymphoma. Neurosurgery 25: 14–19PubMedGoogle Scholar
  105. 106.
    Smadja D, Mas JL, Fallet-Bianco C, Meyniard O, Sicard D, de Recondo J, Rondot P (1991) Intravascular lymphomatosis (neoplastic angioendotheliosis) of the central nervous system: case report and literature review. J Neurooncol 11: 171–180PubMedGoogle Scholar
  106. 107.
    Stern BJ, Krumholz A, Johns C, Scott P, Nissim J (1985) Sarcoidosis and its neurological manifestations. Arch Neurol 42: 909–917PubMedGoogle Scholar
  107. 108.
    Tacconi L, Eccles S, Johnston FG, Symon L (1995) Mycosis fungoides with central nervous system involvement — a case report: T-cell lymphoma of the brain. Surg Neurol 43: 389–392PubMedGoogle Scholar
  108. 109.
    Tomlinson FH, Kurtin PJ, Suman VJ, Scheithauer BW, O’Fallon JR, Kelly PJ, Jack CR Jr, O’Neill BP (1995) Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J Neurosurg 82: 558–566PubMedGoogle Scholar
  109. 110.
    Tondini C, Zanini M, Lombardi F, Bengala C, Rocca A, Giardini R, Buzzoni R, Valagussa P, Bonadonna G (1993) Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive Non-Hodgkin’s lymphomas. J Clin Oncol 11:720–725PubMedGoogle Scholar
  110. 111.
    Verbraeken HE, Hanssens M, Priem H, Lafaut BA, De Laey JJ (1997) Ocular non-Hodgkin’s lymphoma: a clinical study of nine cases. Br J Ophthalmol 81: 31–36PubMedGoogle Scholar
  111. 112.
    von Gunten CF, Von Roenn JH (1992) Clinical aspects of human immunodeficiency virus-related lymphoma. Cur Opin Oncol 4: 894–899Google Scholar
  112. 113.
    Wara WM (1985) Radiation therapy for brain tumors. Cancer 55: 2291–2295PubMedGoogle Scholar
  113. 114.
    Weissman DE, Kueck BD, Merkow AB (1990) A case of large cell CNS lymphoma associated with a systemic small cell lymphocytic lymphoma. J NeuroOncol 9: 171–175PubMedGoogle Scholar
  114. 115.
    Whitcup SM, de Smet MD, Rubin BI, Palestine AG, Martin DF, Burnier M Jr, Chan CC, Nussenblatt RB (1993) Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophtalmology 100: 1399–1406Google Scholar
  115. 116.
    Wick MR, Mills SE, Scheithauer BW, Cooper PH, Davitz MA, Parkinson K (1986) Reassessment of malignant “angioendotheliomatosis”. Evidence in favor of its reclassification as “intravascular lymphomatosis”. Am J Surg Pathol 10: 112–123PubMedGoogle Scholar
  116. 117.
    Winger MJ, Macdonald DR, Schold Jr SC, Cairncross JG (1989) Selection biais in clinical trials of anaplastic glioma. Ann Neurol 26: 531–534PubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2000

Authors and Affiliations

  • H. Loiseau
    • 1
  • E. Cuny
    • 1
  • A. Vital
    • 2
  • F. Cohadon
    • 1
  1. 1.Clinique Universitaire de NeurochirurgieBordeauxFrance
  2. 2.Département d’Anatomopathologie Hôpital Pellegrin TripodeBordeauxFrance

Personalised recommendations